Comment on

• Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial.

  Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, Jereczek-Fossa BA, Cattani F, Sangalli C, Luini A, Caldarella P, Venturino M, Sances D, Zurrida S, Viale G, Leonardi MC, Intra M. Orecchia R, et al. Lancet Oncol. 2021 May;22(5):597-608. doi: 10.1016/S1470-2045(21)00080-2. Epub 2021 Apr 9. Lancet Oncol. 2021. PMID: 33845035 Clinical Trial.
• Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial.

  Fastner G, Reitsamer R, Sedlmayer F. Fastner G, et al. Lancet Oncol. 2021 Jul;22(7):e293. doi: 10.1016/S1470-2045(21)00257-6. Lancet Oncol. 2021. PMID: 34197754 No abstract available.
• Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial.

  Kaidar-Person O, Poortmans P. Kaidar-Person O, et al. Lancet Oncol. 2021 Jul;22(7):e294. doi: 10.1016/S1470-2045(21)00259-X. Lancet Oncol. 2021. PMID: 34197755 No abstract available.
• Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial.

  Vaidya JS, Bulsara M, Massarut S, Sperk E, Wenz F, Tobias JS; TARGIT-A trial authors. Vaidya JS, et al. Lancet Oncol. 2021 Jul;22(7):e295-e296. doi: 10.1016/S1470-2045(21)00278-3. Lancet Oncol. 2021. PMID: 34197756 No abstract available.
• Partial breast irradiation with intraoperative radiotherapy in the ELIOT trial.

  Marta GN, Meattini I. Marta GN, et al. Lancet Oncol. 2021 Jul;22(7):e297. doi: 10.1016/S1470-2045(21)00260-6. Lancet Oncol. 2021. PMID: 34197757 No abstract available.